Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/19/2011 | EP2375905A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control |
10/19/2011 | EP2375904A1 Biaryl carboxamides |
10/19/2011 | EP2375903A1 A method of treating insomnia |
10/19/2011 | EP2375900A1 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles |
10/19/2011 | EP2375899A1 Piperidine-containing compounds and use thereof |
10/19/2011 | EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses |
10/19/2011 | EP2375895A1 Method for treating alzheimer's disease and related conditions |
10/19/2011 | EP2363142A9 Elastase for opening obstructed biological conduits |
10/19/2011 | EP2276759B1 3-indazolyl-4-pyridylisothiazoles |
10/19/2011 | EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
10/19/2011 | EP2221377B1 Oligonucleotide compositions with enhanced efficiency |
10/19/2011 | EP2214628B1 Orodispersible composition comprising polyunsaturated fatty acids without bad odour or taste |
10/19/2011 | EP2187767B1 Increased creatine retention with soluble fibres |
10/19/2011 | EP2170857B1 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same |
10/19/2011 | EP2162125B1 Composition for rectal administration combined with an oral alpha-lipoic acid composition for the treatment of inflammatory bowel disease |
10/19/2011 | EP2101569B1 Crystalline solid rasagiline base |
10/19/2011 | EP2018380B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives |
10/19/2011 | EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof |
10/19/2011 | EP1968601B1 Salts of potassium atp channel openers and uses thereof |
10/19/2011 | EP1966209B1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders |
10/19/2011 | EP1965798B1 Useful monobactam antibiotics |
10/19/2011 | EP1957451B1 Soft anticholinergic zwitterions |
10/19/2011 | EP1948596B1 Soft anticholinergic esters |
10/19/2011 | EP1937250B1 Ligustilide derivatives for the treatment of inflammatory disorders |
10/19/2011 | EP1923387B1 Acylguanidine derivative or salt thereof |
10/19/2011 | EP1917012B1 Cell migration modulating compounds |
10/19/2011 | EP1910379B1 Caspase inhibitor prodrugs |
10/19/2011 | EP1899302B1 Phenoxy acetic acids as ppar delta activators |
10/19/2011 | EP1896473B1 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication |
10/19/2011 | EP1891075B1 Tricyclic spiro derivatives as crth2 modulators |
10/19/2011 | EP1871380B1 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders |
10/19/2011 | EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
10/19/2011 | EP1809379B1 Process for preparing (3-(2(r)-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3(s)-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-4,5-dihydro-(1,2,4)-triazol-1-yl) phosphonic acid |
10/19/2011 | EP1782831B1 External preparation |
10/19/2011 | EP1782816B1 Water-based medicinal composition containing azithromycin and method of preparing the same |
10/19/2011 | EP1773310B1 Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof |
10/19/2011 | EP1735332B1 Azacyclosteroid histamine-3 receptor ligands |
10/19/2011 | EP1694334B1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
10/19/2011 | EP1687024B1 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
10/19/2011 | EP1640371B1 Flavanone compound and uses thereof |
10/19/2011 | EP1622597B1 Modulation of apolipoprotein c-iii expression |
10/19/2011 | EP1613598B1 Methods of preparing aripiprazole crystalline forms |
10/19/2011 | EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors |
10/19/2011 | EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
10/19/2011 | EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
10/19/2011 | EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
10/19/2011 | EP1341524B1 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient |
10/19/2011 | EP1282615B1 Chroman derivatives as estrogenic compounds |
10/19/2011 | EP1233966B2 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
10/19/2011 | EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
10/19/2011 | EP1139974B1 Soy depigmenting and skin care compositions |
10/19/2011 | EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
10/19/2011 | EP0910253B2 Peri-operative drink |
10/19/2011 | DE202011004860U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von als negativ empfundener Geruchsbelästigung von Stoffwechselprodukten über Mund- und/oder Nasenhöhle und/oder Urin und/oder Stuhl Drugs, or dietary supplements for the treatment and / or prophylaxis of perceived negative odor of metabolites through oral and / or nasal cavity and / or urine and / or stool |
10/19/2011 | CN202010289U Combined capsule containing hydrochlorothiazide solid formulation and aliskiren solid formulation |
10/19/2011 | CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
10/19/2011 | CN1980671B Liposome preparation containing slightly water-soluble camptothecin |
10/19/2011 | CN1964627B Methods and compositions for treating neuropathies |
10/19/2011 | CN1874692B Lipid system and method of use |
10/19/2011 | CN1706385B New composition for treating seasonal and perennial allergic rhinitis |
10/19/2011 | CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease |
10/19/2011 | CN1251097B Phthalazines with angiogenesis inhibiting activity |
10/19/2011 | CN102224252A Novel compound signamycin, method for production thereof, and use thereof |
10/19/2011 | CN102224242A Novel gene cluster |
10/19/2011 | CN102224159A Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases |
10/19/2011 | CN102224156A Protease inhibitors |
10/19/2011 | CN102224155A Protease inhibitors |
10/19/2011 | CN102224154A Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
10/19/2011 | CN102224153A Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors |
10/19/2011 | CN102224152A Pyrazolopyridine pi3k inhibitor compounds and methods of use |
10/19/2011 | CN102224144A Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine |
10/19/2011 | CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
10/19/2011 | CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity |
10/19/2011 | CN102224141A Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
10/19/2011 | CN102224139A Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
10/19/2011 | CN102224138A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
10/19/2011 | CN102224136A 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
10/19/2011 | CN102224135A Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
10/19/2011 | CN102223915A New therapy and medicament using integrin ligands for treating cancer |
10/19/2011 | CN102223897A Anti-angiogenesis therapy for the treatment of breast cancer |
10/19/2011 | CN102223896A Anti-beta-2-microglobulin agents and the use thereof |
10/19/2011 | CN102223886A Erbb-3 (her3)-selective combination therapy |
10/19/2011 | CN102223885A Cdk inhibitor for the treatment of mesothelioma |
10/19/2011 | CN102223884A Solid pharmaceutical composition |
10/19/2011 | CN102223883A Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy |
10/19/2011 | CN102223882A Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
10/19/2011 | CN102223880A Orally rapidly disintegrating tablet, and process for producing same |
10/19/2011 | CN102223878A Liposomal systems comprising sphingomyelin |
10/19/2011 | CN102223875A Pharmaceutical composition of a potent hcv inhibitor for oral administration |
10/19/2011 | CN102223797A Adamantyl benzamide compounds |
10/19/2011 | CN102223791A Topical formulations for treatment of neuropathy |
10/19/2011 | CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
10/19/2011 | CN102219826A Polymorphs of sarsapogenin |
10/19/2011 | CN102219822A Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
10/19/2011 | CN102219821A Cardiac glycoside compounds and antitumor application thereof |
10/19/2011 | CN102219815A Six tiacumicins compounds, preparation method and use of six tiacumicins compounds in preparing antibacterial drugs |
10/19/2011 | CN102219812A Tumor targeting deoxyglucose composite drug and preparation method thereof |
10/19/2011 | CN102219811A CA-4 derivatives and preparation method and medicinal application thereof |
10/19/2011 | CN102219784A Heteroaryl urea derivatives useful for inhibiting CHKl |
10/19/2011 | CN102219783A Vilazodone hydrochloride and composition thereof |